MARK A SCHLOSSBERG Insider Trading $IPXL Impax Laboratories, LLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK A SCHLOSSBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK A SCHLOSSBERG. MARK A SCHLOSSBERG is SVP and General Counsel in IMPAX LABORATORIES INC ($IPXL) and Director in ImmunoCellular Therapeutics, Ltd. ($IMUC) and SVP - Legal & General Counsel in CYTOKINETICS INC ($CYTK).
MARK A SCHLOSSBERG in Impax Laboratories, LLC
Trading Symbol: IPXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK A SCHLOSSBERG: SVP and General Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK A SCHLOSSBERG in Impax Laboratories, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CYTK, IMUC, IPXL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 21.24 | 100,000 | 2,124,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 20.90 | 21,667 | 452,840 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 17.99 | 52,000 | 935,480 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 25.24 | 55,000 | 1,388,200 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 40.70 | 47,500 | 1,933,250 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 33.27 | 52,801 | 1,756,689 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | D | 0.00 | 18,135 | 0 | 0 | 18.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | D | 0.00 | 50,116 | 0 | 0 | 50.1 K to 0 (-100.00 %) |
Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 19.50 | 3,273 | 63,824 | 89,246 | 92.5 K to 89.2 K (-3.54 %) |
Feb 27 2018 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 20.95 | 5,937 | 124,380 | 92,519 | 98.5 K to 92.5 K (-6.03 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 16.80 | 3,488 | 58,598 | 98,456 | 101.9 K to 98.5 K (-3.42 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 17.65 | 3,235 | 57,098 | 101,944 | 105.2 K to 101.9 K (-3.08 %) |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 23,272 | 0 | 105,179 | 81.9 K to 105.2 K (+28.41 %) |
Feb 27 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 14.05 | 6,014 | 84,497 | 81,907 | 87.9 K to 81.9 K (-6.84 %) |
May 24 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 32.12 | 1,095 | 35,171 | 87,921 | 89 K to 87.9 K (-1.23 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 29.18 | 2,330 | 67,989 | 89,016 | 91.3 K to 89 K (-2.55 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 29.18 | 2,163 | 63,116 | 91,346 | 93.5 K to 91.3 K (-2.31 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 33.27 | 52,801 | 1,756,689 | 52,801 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 21,852 | 0 | 93,509 | 71.7 K to 93.5 K (+30.50 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 33.27 | 1,931 | 64,244 | 71,657 | 73.6 K to 71.7 K (-2.62 %) |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | S | 43.30 | 7,457 | 322,888 | 73,588 | 81 K to 73.6 K (-9.20 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | S | 43.41 | 4,649 | 201,813 | 81,045 | 85.7 K to 81 K (-5.43 %) |
Jul 09 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 45.99 | 3,916 | 180,097 | 85,694 | 89.6 K to 85.7 K (-4.37 %) |
May 26 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 46.21 | 1,102 | 50,923 | 89,610 | 90.7 K to 89.6 K (-1.21 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 44.44 | 2,330 | 103,545 | 90,712 | 93 K to 90.7 K (-2.50 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 44.82 | 2,163 | 96,946 | 93,042 | 95.2 K to 93 K (-2.27 %) |
Mar 12 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 40.70 | 47,500 | 1,933,250 | 47,500 | |
Mar 12 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 20,000 | 0 | 95,205 | 75.2 K to 95.2 K (+26.59 %) |
Jul 16 2014 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 28.80 | 2,819 | 81,187 | 75,205 | 78 K to 75.2 K (-3.61 %) |
May 28 2014 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 27.89 | 815 | 22,730 | 78,024 | 78.8 K to 78 K (-1.03 %) |
May 16 2014 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 25.24 | 55,000 | 1,388,200 | 55,000 | |
May 16 2014 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 25.56 | 2,330 | 59,555 | 78,839 | 81.2 K to 78.8 K (-2.87 %) |
May 16 2014 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 23,000 | 0 | 81,169 | 58.2 K to 81.2 K (+39.54 %) |
Jul 09 2013 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 20.33 | 2,752 | 55,951 | 58,169 | 60.9 K to 58.2 K (-4.52 %) |
May 28 2013 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 18.60 | 795 | 14,787 | 60,921 | 61.7 K to 60.9 K (-1.29 %) |
May 16 2013 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 17.99 | 52,000 | 935,480 | 52,000 | |
May 16 2013 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 24,800 | 0 | 61,716 | 36.9 K to 61.7 K (+67.18 %) |
Mar 14 2013 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Buy | P | 16.73 | 1,000 | 16,728 | 36,916 | 35.9 K to 36.9 K (+2.78 %) |
Jul 09 2012 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 20.25 | 2,751 | 55,708 | 35,916 | 38.7 K to 35.9 K (-7.11 %) |
May 25 2012 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 20.90 | 21,667 | 452,840 | 21,667 | |
May 25 2012 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 8,667 | 0 | 38,667 | 30 K to 38.7 K (+28.89 %) |
Jul 11 2011 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 21.24 | 100,000 | 2,124,000 | 100,000 | |
Jul 11 2011 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Page: 1